Aren the farmers currently growing pharma crops reaping financial rewards?
A small group of farmers is currently growing pharma crops and there are reports that they are being paid premium prices. This makes sense because the companies are anxious to enlist the support of the farm community for this application of biotechnology. The question is whether companies would continue to pay premium prices once the industry was established and they were in a position to drive down their costs by forcing farmers to compete for their business.
